Weiqing Chen

1.7k total citations
65 papers, 836 citations indexed

About

Weiqing Chen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiqing Chen has authored 65 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 20 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiqing Chen's work include Colorectal Cancer Screening and Detection (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Weiqing Chen is often cited by papers focused on Colorectal Cancer Screening and Detection (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Drug Transport and Resistance Mechanisms (9 papers). Weiqing Chen collaborates with scholars based in China, United States and Spain. Weiqing Chen's co-authors include Ronald T. Borchardt, Xu Tian, Jerry Z. Yang, Xiaoling Liu, William N. Charman, Brendan M. Johnson, Christopher J. H. Porter, Bente Steffansen, Hui Ouyang and María Herrera and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Developmental Cell.

In The Last Decade

Weiqing Chen

64 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqing Chen China 17 382 189 164 128 74 65 836
Diane Liu United States 17 225 0.6× 216 1.1× 146 0.9× 53 0.4× 43 0.6× 27 981
Eugene Chang United States 26 429 1.1× 788 4.2× 165 1.0× 151 1.2× 220 3.0× 50 1.8k
Sławomir Rudzki Poland 12 254 0.7× 138 0.7× 96 0.6× 115 0.9× 34 0.5× 48 748
Kunal K. Sindhu United States 14 130 0.3× 234 1.2× 120 0.7× 181 1.4× 38 0.5× 89 1.2k
Akio Nakashima Japan 16 103 0.3× 221 1.2× 105 0.6× 117 0.9× 24 0.3× 76 944
E. E. Calle United States 10 408 1.1× 163 0.9× 120 0.7× 96 0.8× 34 0.5× 10 1.2k
Maria Rita Lusso Italy 16 238 0.6× 374 2.0× 162 1.0× 90 0.7× 77 1.0× 20 1.3k
Fen Jiang China 15 252 0.7× 131 0.7× 83 0.5× 114 0.9× 14 0.2× 58 847
Masashi Ishihara Japan 14 136 0.4× 97 0.5× 126 0.8× 218 1.7× 13 0.2× 53 744

Countries citing papers authored by Weiqing Chen

Since Specialization
Citations

This map shows the geographic impact of Weiqing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqing Chen more than expected).

Fields of papers citing papers by Weiqing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqing Chen. The network helps show where Weiqing Chen may publish in the future.

Co-authorship network of co-authors of Weiqing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqing Chen. A scholar is included among the top collaborators of Weiqing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqing Chen. Weiqing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Fei, Jie Zhu, Weiqing Chen, et al.. (2025). Lymphatic endothelial mTORC1 instructs metabolic and developmental signaling during lymphangiogenesis. Developmental Cell. 60(17). 2331–2347.e6. 1 indexed citations
2.
Xu, Jianming, Yanqiao Zhang, Gang Wang, et al.. (2024). SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A randomized phase 3 trial.. Journal of Clinical Oncology. 42(16_suppl). 4092–4092. 8 indexed citations
3.
Dai, Xiaomei, et al.. (2023). The role of PD-1 signaling in health and immune-related diseases. Frontiers in Immunology. 14. 1163633–1163633. 73 indexed citations
4.
Tian, Xu, et al.. (2022). Network meta-analysis of the optimal time of applying enteral immunonutrition in esophageal cancer patients receiving esophagectomy. Supportive Care in Cancer. 30(9). 7133–7146. 4 indexed citations
5.
Chen, Cheng, et al.. (2022). Oral sulfate solution benefits polyp and adenoma detection during colonoscopy: Meta‐analysis of randomized controlled trials. Digestive Endoscopy. 34(6). 1121–1133. 12 indexed citations
6.
7.
Tian, Xu, et al.. (2020). Enhanced Patient Education for Colonic Polyp and Adenoma Detection: Meta-Analysis of Randomized Controlled Trials. JMIR mhealth and uhealth. 8(6). e17372–e17372. 14 indexed citations
8.
9.
10.
11.
12.
13.
Tian, Xu, et al.. (2018). Efficacy and safety of oral zinc sulfate in the prevention of chemotherapy-induced oral mucositis. Medicine. 97(21). e10839–e10839. 5 indexed citations
14.
Wang, Yulan, et al.. (2016). HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis. Molecular and Clinical Oncology. 4(6). 1045–1051. 16 indexed citations
15.
Li, Zhibin, Qinghua Liu, Haiping Mao, et al.. (2012). Gender Difference in the Association of Hyperuricemia with Chronic Kidney Disease in Southern China. Kidney & Blood Pressure Research. 36(1). 98–106. 11 indexed citations
16.
Su, Yi, Lijuan Chen, Jianrong He, et al.. (2011). Urinary rubidium in breast cancers. Clinica Chimica Acta. 412(23-24). 2305–2309. 27 indexed citations
17.
Chen, Lijuan, Lu-Ying Tang, Jianrong He, et al.. (2011). Urinary strontium and the risk of breast cancer: A case-control study in Guangzhou, China. Environmental Research. 112. 212–217. 16 indexed citations
18.
Ouyang, Hui, et al.. (2008). Factors that restrict intestinal cell permeation of cyclic prodrugs of an opioid peptide (DADLE): Part II. Role of metabolic enzymes in the intestinal mucosa. Journal of Pharmaceutical Sciences. 98(1). 349–361. 7 indexed citations
19.
20.
Yang, Jerry Z., Weiqing Chen, & Ronald T. Borchardt. (2002). In Vitro Stability and In Vivo Pharmacokinetic Studies of a Model Opioid Peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and Its Cyclic Prodrugs. Journal of Pharmacology and Experimental Therapeutics. 303(2). 840–848. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane Liu Breakdown of academic impact, for papers by Eugene Chang Breakdown of academic impact, for papers by Sławomir Rudzki Breakdown of academic impact, for papers by Kunal K. Sindhu Breakdown of academic impact, for papers by Akio Nakashima Breakdown of academic impact, for papers by E. E. Calle Breakdown of academic impact, for papers by Maria Rita Lusso Breakdown of academic impact, for papers by Fen Jiang Breakdown of academic impact, for papers by Masashi Ishihara
Rankless by CCL
2026